Letter to the Editor
15 July 2019 / 17 April 2024 by almaware | Leave a Comment
Read more »
Original Article
Brief report
Review
15 July 2019 / 23 May 2024 by almaware | Leave a Comment
Background. Heterogeneity in the design and quality of trials evaluating allergy immunotherapies (AITs) limits their comparability, making it difficult for physicians, patients, and payers to select the best treatment option. Methods. This systematic review evaluated the quality of randomised controlled trials (RCTs) of registered grass AITs using the National Institute of Health and Care Excellence checklist. Results. 17 of 44 […]